News

The company’s co-founder, Aneel Bhusri, who has previously served as chief executive, will replace Eschenbach.  

AI hyperscalers had a bruising week after investors got jittery about huge expenditure outlooks.  

The moves come after the major averages bounced back Friday from sizable losses suffered earlier in the week.  

About 1.1 million homeowners were underwater on their mortgages at the end of last year as home prices stalled, signaling a deepening crisis within the housing market.  

Amber Enterprises India Limited has submitted to the Exchange, the Outcome of Board Meeting held on 09th February 2026, to discuss the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2025. |SUBJECT: Outcome of Board Meeting  

Amber Enterprises India Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation  

Amber Enterprises India Limited has informed the Exchange regarding a press release dated February 10, 2026, titled “Press Release dated 10th February 2026 on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter and nine months ended 31st December 2025”. |SUBJECT: Press Release  

Pursuant to Regulation 32(6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Regulations 82 and 173A of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, we are enclosing herewith the Monitoring Agency Report for the quarter ended 31st December 2025 issued by CARE Ratings Limited, Monitoring Agency, appointed to monitor the utilization of proceeds raised through issuance of Equity Shares by way of Qualified Institutions Placement ( QIP ). |SUBJECT: Monitoring Agency Report  

Completion of the acquisition of Unbound Medicine, Inc., USA, by MPS North America LLC, a wholly owned subsidiary of the Company. |SUBJECT: Acquisition  

MPS Limited has informed the Exchange about a conference call on Wednesday, 18 February 2026, on the acquisition of Unbound Medicine Inc., USA. |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates